Pigeon Corporation (TYO:7956)
Japan · Delayed Price · Currency is JPY 1,642.50
+45.00 (2.82%)
At close: Mar 6, 2026
Pigeon Revenue
In the year 2025, Pigeon had annual revenue of 109.17B JPY with 4.80% growth. Pigeon had revenue of 28.64B in the quarter ending December 31, 2025, with 1.81% growth.
Revenue
109.17B
Revenue Growth
+4.80%
P/S Ratio
1.80
Revenue / Employee
35.61M
Employees
3,066
Market Cap
196.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 109.17B | 5.00B | 4.80% |
| Dec 31, 2024 | 104.17B | 9.71B | 10.28% |
| Dec 31, 2023 | 94.46B | -460.00M | -0.48% |
| Dec 31, 2022 | 94.92B | 1.84B | 1.98% |
| Dec 31, 2021 | 93.08B | -6.30B | -6.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Paltac | 1.23T |
| Lion Corporation | 422.09B |
| Rohto Pharmaceutical | 335.80B |
| KOSE Holdings | 330.19B |
| Earth | 179.18B |
| Pola Orbis Holdings | 170.29B |
| Kobayashi Pharmaceutical | 165.74B |
| MTG Co., Ltd. | 109.56B |